Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
US-2025127916-A1 · Apr 24, 2025 · US
This page is not indexed by search engines while we improve data quality.
Emergence Therapeutics Gmbh — Human Necessities
Emergence Therapeutics Gmbh holds 3 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Emergence Therapeutics Gmbh |
| Technology | Human Necessities |
| Patents in slice | 3 |
| Recent patents in slice | 3 |
| First year | 2024 |
| Last year | 2025 |
Representative patents
Notable publications linking Emergence Therapeutics Gmbh to Human Necessities.
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
US-2025127916-A1 · Apr 24, 2025 · US
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
US-2025127916-A1 · Apr 24, 2025 · US
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
US-2025127916-A1 · Apr 24, 2025 · US
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
US-2025127916-A1 · Apr 24, 2025 · US
Recent filings
Latest patents from Emergence Therapeutics Gmbh in Human Necessities.
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
US-2025127916-A1 · Apr 24, 2025 · US
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
US-2025127916-A1 · Apr 24, 2025 · US
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
US-2025127916-A1 · Apr 24, 2025 · US
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
US-2025127916-A1 · Apr 24, 2025 · US
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
US-2025127916-A1 · Apr 24, 2025 · US
Related pages
Navigate to parent entity pages.